Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
life sciences
2
×
national blog main
allergan
amgen
biotech
boston
cholesterol
crispr
cynthia collins
data
drugs
editas medicine
gene editing
inclisiran
katrine bosley
ldl
leber congenital amaurosis
mark timney
mt sinai hospital
national top stories
new york
new york blog main
new york top stories
pcsk9
peter wijngaard
praluent
prashant vaishnava
regeneron pharmaceuticals
repatha
san francisco blog main
san francisco top stories
sanofi
the medicines co.
What
ceo
medicine
2
×
test
2
×
aces
allergan
announced
big
blessing
bosley
check
cholesterol
clinical
crispr
cusp
depart
drug
editas
editing
experimental
flexible
gene
humans
inclisiran
katrine
key
lowering
meant
medco
medicines
million
nasdaq
open
partner
passed
pricing
regulatory
taken
therapy
trial
twice
Language
unset
Current search:
test
×
medicine
×
" life sciences "
×
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
